<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>614</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15050296</PubmedId>
            <Abstract>Large clonal expansions of peripheral CD8(+) T cells carrying receptors for single epitopes of CMV are common in the elderly and may be associated with an immune risk phenotype predicting mortality. To study the effect of ageing on the ability of CMV-specific CD8(+) T cells to produce type 1- and type 2-cytokines, interferon-gamma-and IL-10-producing, CD8(+) T cell responses in the presence of CMV peptide antigen were measured in CMV-seropositive old and young donors. We found that large expansions of A2/NLV-specific CD8(+) T lymphocytes in the elderly are accompanied by a partial loss of antigen responsiveness as reflected in a greatly decreased frequency of antigen-specific IFN-gamma-and IL-10-producing cells. Thus, despite carrying specific antigen receptors, the majority of the clonally expanded CMV-specific CD8(+) cells in the elderly was dysfunctional according to these criteria. Our data indicated a bias towards a more anti-inflammatory response in the elderly. The accumulation of dysfunctional CMV-specific cells might fill the 'immunological space' and decrease the available repertoire of T cells for novel antigens. This might account for the increased incidence of many infectious diseases in the elderly.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>607-13</ArticlePages>
            <ArticleTitle>Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Ouyang</LastName>
                    <ForeName>Qin</ForeName>
                </Author>
                <Author>
                    <LastName>Wagner</LastName>
                    <ForeName>Wolfgang M</ForeName>
                </Author>
                <Author>
                    <LastName>Zheng</LastName>
                    <ForeName>Wei</ForeName>
                </Author>
                <Author>
                    <LastName>Wikby</LastName>
                    <ForeName>Anders</ForeName>
                </Author>
                <Author>
                    <LastName>Remarque</LastName>
                    <ForeName>Ed J</ForeName>
                </Author>
                <Author>
                    <LastName>Pawelec</LastName>
                    <ForeName>Graham</ForeName>
                </Author>
            </Authors>
            <Affiliations>Tübingen Ageing and Tumour Immunology Group, Section for Transplantation Immunology and Immunohematology, University of Tübingen, Tübingen, Germany. qouyang@bccrc.ca</Affiliations>
            <ArticleChemicalList>Antigens, Viral;Epitopes, T-Lymphocyte;Interleukin-10;Interferon-gamma</ArticleChemicalList>
            <ArticleMeshHeadingsList>Adult; Aged; Aged, 80 and over; Aging(immunology); Antigens, Viral(immunology); CD8-Positive T-Lymphocytes(immunology); Cells, Cultured; Cytomegalovirus(immunology); Epitopes, T-Lymphocyte(immunology); Female; Humans; Interferon-gamma(biosynthesis); Interleukin-10(biosynthesis); Lymphocyte Activation(immunology); Male</ArticleMeshHeadingsList>
            <Journal>
                <Volume>39</Volume>
                <Issue>4</Issue>
                <Title>Experimental gerontology</Title>
                <Issn>0531-5565</Issn>
                <MedlineTa>Exp Gerontol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>A2/NLV</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NLVPMVATV</LinearSequence>
                        <StartingPosition>495</StartingPosition>
                        <EndingPosition>503</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P06725.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10359</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 608</LocationOfData>
                <EpitopeId>44920</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>5755</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Human herpesvirus 5</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A2+ and CMV seropositive elderly individuals (mean age of the participants was 89.7 yr, 54% women) were studied.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>PBMC</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>A2/NLV</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLVPMVATV</LinearSequence>
                                        <StartingPosition>495</StartingPosition>
                                        <EndingPosition>503</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P06725.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>13</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>13</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>In addition to this elderly group samples, CD8+ T cells from 9 young subjects (HLA-A2-positive and CMV-seropositive, mean age 36.2 years) were also assayed and showed significantly higher responses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <TCellId>5751</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <Age>89.7 years</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Exposure with existing immune reactivity without evidence for disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>10359</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Human herpesvirus 5</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                            </InVitroAdministration>
                            <ImmunizationComments>HLA-A2+ and CMV seropositive elderly individuals (mean age of the participants was 89.7 yr, 54% women) were studied.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>235</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -Single MHC type present</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>A2/NLV</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>NLVPMVATV</LinearSequence>
                                        <StartingPosition>495</StartingPosition>
                                        <EndingPosition>503</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P06725.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10359</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>47</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>13</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>13</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>In addition to this elderly group samples, CD8+ T cells from 9 young subjects (HLA-A2-positive and CMV-seropositive, mean age 36.2 years) were also assayed and showed significantly lower responses.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

